ClinicalTrials.Veeva

Menu

Effect of Oliceridine on Rebound Pain

Xiamen University logo

Xiamen University

Status

Enrolling

Conditions

Oliceridine
Arthroscopic Knee Surgery
Rebound Pain

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06382896
FirstAHXiamenU-YB-2

Details and patient eligibility

About

The purpose of this clinical study was to identify the risk factors for postoperative pain outburst in patients undergoing arthroscopic knee surgery after Oliceridine and nerve block, and to evaluate the effect of oxeridine on early rehabilitation exercise in patients. A total of 320 patients undergoing arthroscopic knee arthroscopy under general anesthesia combined with femoral nerve block were selected to record the time and duration of postoperative pain outbreak, pain degree, age, gender, operation type, previous surgical history and other related risk factors.

Enrollment

320 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18-70 years old;2. Body mass index (BMI) 18-30kg /m2;3. American Society of Anesthesiologists (ASA) Grade I to II;4. Hospital stay >24h.

Exclusion criteria

  1. Patients who cannot understand the numerical rating scale score and give feedback;2. Known allergy to the drug in the study;3. Infection of puncture site with nerve block;4. Oral analgesics for more than 2 weeks before surgery;5. Long-term use of glucocorticoids;6. Simultaneous surgery on both limbs;7. A psychopath;8. Severe compound trauma;9. Pregnant and lactating women.

Trial design

320 participants in 1 patient group

Patients undergoing ambulatory arthroscopic knee surgery
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Bin Yang, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems